Efficacy of anticholinergic drugs in asthma

Expert Review of Respiratory Medicine

Volumn 6, Issue 3, 2012, Pages 309-319

  Novelli, Federica ^a   Malagrinò, Laura ^a   Dente, Federico L ^a   Paggiaro, Pierluigi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

anticholinergics; asthma; ipratropium; phenotypes; tiotropium

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; RESPIMAT; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; FORCED EXPIRATORY VOLUME; LOW DRUG DOSE; MEDICAL HISTORY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE;

EID: 84863948273     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.12.27     Document Type: Review

References (40)

1. Belmonte KE. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2(4), 297-304 (2005
2. Lewis MJ, Short AL, Lewis KE. Autonomic nervous system control of the cardiovascular and respiratory systems in asthma. Respir. Med. 100(10), 1688-1705 (2006
3. Sheppard D, Epstein J, Skoogh BE, Bethel RA, Nadel JA, Boushey HA. Variable inhibition of histamine-Induced bronchoconstriction by atropine in subjects with asthma. J. Allergy Clin. Immunol. 73(1 Pt 1), 82-87 (1984
4. Fabbri LM, Hendrick DJ, Diem JE. Effect of atropine on the bronchial response of asthmatic subjects to the inhalation of ultrasonically nebulized distilled water. J. Allergy Clin. Immunol. 71(5), 468-472 (1983
5. Sheppard D, Epstein J, Holtzman MJ, Nadel JA, Boushey HA. Dose-Dependent inhibition of cold air-Induced bronchoconstriction by atropine. J. Appl. Physiol. 53(1), 169-174 (1982
6. Fish JE, Rosenthal RR, Summer WR, Menkes H, Norman PS, Permutt S. The effect of atropine on acute antigenmediated airway constriction in subjects with allergic asthma. Am. Rev. Respir. Dis. 115(3), 371-379 (1977
7. Ruffin RE, Cockcroft DW, Hargreave FE. A comparison of the protective effect of fenoterol and Sch 1000 on allergeninduced asthma. J. Allergy Clin. Immunol. 61(1), 42-47 (1978
8. Cockcroft DW, Ruffin RE, Hargreave FE. Effect of Sch1000 in allergen-Induced asthma. Clin. Allergy 8(4), 361-372 (1978
9. Paggiaro P, Bacci E, Talini D et al. Atropine does not inhibit late asthmatic responses induced by toluene-Diisocyanate in sensitized subjects. Am. Rev. Respir. Dis. 136(5), 1237-1241 (1987
10. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: A systematic review with meta-Analysis. Thorax 60(9), 740-746 (2005
11. Petrie GR, Palmer KN. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. Br. Med. J. 1(5955), 430-432 (1975
12. Ruffin RE, Fitzgerald JD, Rebuck AS. A comparison of the bronchodilator activity of Sch 1000 and salbutamol. J. Allergy Clin. Immunol. 59(2), 136-141 (1977
13. Thiessen B, Pedersen OF Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide. Respiration. 43(4), 304-316 (1982
14. Jindal SK, Kaur SJ. Relative bronchodilatory responsiveness attributable to sympathetic and parasympathetic activity in bronchial asthma. Respiration 56(1-2), 16-21 (1989
15. Boulet LP, Turcotte H, Tennina S. Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges. J. Allergy Clin. Immunol. 83(5), 882-887 (1989
16. Higgins BG, Powell RM, Cooper S, Tattersfield AE. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur. Respir. J. 4(4), 415-420 (1991
17. Chhabra SK, Pandey KK. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma. J. Asthma 39(5), 375-381 (2002
18. Delpierre S, Guillot C, Badier M. Same efficacies of ipratropium and salbutamol in reversing methacholine-Induced bronchoconstriction. J. Asthma 43(9), 679-685 (2006
19. Gelb AF, Karpel J, Wise RA, Cassino C, Johnson P, Conoscenti CS. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-To-Severe persistent asthma. Pulm. Pharmacol. Ther. 21(4), 630-636 (2008
20. Ahmad Z, Singh SK. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics. J. Asthma 47(3), 340-343 (2010
21. Cox ID, Hughes DT, McDonnell KA. Ipratropium bromide in patients with nocturnal asthma. Postgrad. Med. J. 60(706), 526-528 (1984
22. Haney S, Hancox RJ. Overcoming beta-Agonist tolerance: High dose salbutamol and ipratropium bromide. Two randomized controlled trials. Respire Res. 6, 8-19 (2007
23. Tashkin DP, Celli B, Senn S et al.; UPLIFT Study Investigators. A 4-Year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359(15), 1543-1554 (2008
24. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir. Med. 102(1), 50-56 (2008
25. Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir. Med. 101(6), 1218-1228 (2007
26. Kerstjens HA, Disse B, Schröder-Babo W et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial. J. Allergy Clin. Immunol. 128(2), 308-314 (2011
27. Peters SP, Kunselman SJ, Icitovic N et al.; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med. 363(18), 1715-1726 (2010
28. Wechsler ME, Lehman E, Lazarus SC et al.; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Beta-Adrenergic receptor polymorphisms and response to salmeterol. Am. J. Respir. Crit. Care Med. 173(5), 519-526 (2006
29. Park HW, Yang MS, Park CS et al. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy 64(5), 778-783 (2009
30. Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J. Allergy Clin. Immunol. 128(2), 315-322 (2011
31. Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to longacting beta2-Agonist therapy: A pharmacogenetic analysis of two randomised studies. Lancet 370(9605), 2118-2125 (2007
32. Bleecker ER, Nelson HS, Kraft M et al. Beta2-Receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am. J. Respir. Crit. Care Med. 181(7), 676-687 (2010
33. Iwamoto H, Yokoyama A, Shiota N et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur. Respir. J. 31(6), 1379-1380 (2008
34. Hardin M, Silverman EK, Barr RG et al.; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir. Res. 12, 127 (2011
35. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur. Respir. J. 30(3), 452-456 (2007
36. Pauwels RA, Löfdahl CG, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N. Engl. J. Med. 337(20), 1405-1411 (1997
37. Bateman ED, Rennard S, Barnes PJ et al. Alternative mechanisms for tiotropium. Pulm. Pharmacol. Ther. 22(6), 533-542 (2009
38. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: INSIGHTS from clinical studies. Proc. Am. Thorac. Soc. 6(3), 256-259 (2009
39. Van Der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 59(8), 713-721 (2004
40. Verbanck S, Schuermans D, Vincken W. Small airways ventilation heterogeneity and hyperinflation in COPD: Response to tiotropium bromide. Int. J. Chron. Obstruct. Pulmon. Dis. 2(4), 625-634 (2007